EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Circulating exosome-circRNAs mediated downregulation of FGF9 through ceRNA mechanism aggravates renal fibrosis in diabetic nephropathy

Donglin Yang, Rongjiang Yin, Xiaomin Zhang, Xiaohui Wang, Xiaobin Pei, Zijie Guo, Pengyue Qiao, Kehan Zhu, Lin Wang, Pengchao Du iD

PLOS One · 2025

DOI: 10.1371/journal.pone.0326217 ↗

Kurz gefasst

Fachartikel in der Zeitschrift PLOS One, 2025. Verfasst von Donglin Yang und 9 weiteren Autor:innen. Beteiligte Einrichtung: College of Basic Medical, Binzhou Medical University, Yantai, Shandong, P.R. China. Hauptthemen laut MEDLINE: RNA, Circular, Diabetic Nephropathies, Exosomes, Fibroblast Growth Factor 9. Die Arbeit wurde bisher 2-mal zitiert (Crossref) und nennt 61 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: The present study was supported by Shandong Natural Science Fund of Shandong Province, Introduction of Talent Research Initiation Fund of Central Hospital Affiliated to Shandong First Medical University, The Projects of Medical and Health Technology Development Program in Shandong Province.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Diabetic nephropathy (DN) is one of the most serious microvascular complications of diabetes mellitus. It is characterized by progressive tubulointerstitial fibrosis. The aim of this study was to investigate the role of exosomal circular RNA (circRNAs) in regulating fibroblast growth factor 9 (FGF9) expression in DN through a competitive endogenous RNA (ceRNA) mechanism, and to reveal its potential therapeutic targets. Exosomes were isolated from serum of 3 healthy people and 3 patients with DN by ultra-fast centrifugation method, and the circRNA-miRNA-FGF9 regulatory network was constructed by combining high-throughput circRNA sequencing, bioinformatics analysis and weighted co-expression network (WGCNA). The results showed that the expression of circRNAs in serum exosomes of DN patients was significantly down-regulated, and hsa_circ_0006382 and hsa_circ_0019539 targeted the expression of FGF9 by binding to miR-34a-5p, miR-766-3p, miR-147a and miR-27a-3p. Further verification showed that the expression of FGF9 was decreased in renal tissues of DN patients (AUC = 0.902), and its recombinant protein could inhibit the expression of α-SMA and vimentin in high glucose-induced NRK-52E cells, indicating that activation of the circRNA/miRNA-FGF9 network promotes the EMT of renal tubular epithelial cells. This study revealed for the first time the mechanism of the circRNA-miRNA-FGF9 regulatory network in DN fibrosis, providing a theoretical basis for the development of diagnostic markers and targeted therapy strategies based on exosomal circRNA.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

RNA, CircularDiabetic NephropathiesExosomesFibroblast Growth Factor 9KidneyHumansFibrosisMicroRNAsMaleDown-RegulationFemaleAnimalsMiddle AgedRatsCell LineGene Regulatory NetworksRNA, Competitive Endogenous

Substanzen

RNA, CircularFibroblast Growth Factor 9MicroRNAsFGF9 protein, humanRNA, Competitive Endogenous

Autor:innen und Institutionen

  • College of Basic Medical, Binzhou Medical University, Yantai, Shandong, P.R. China.
  • Department of Thoracic Surgery, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong, P.R. China.
  • Department of Nephrology, Binzhou Medical University Hospital, Binzhou, Shandong, P.R. China.
  • Department of Endocrinology, Yantai Affiliated Hospital of Binzhou Medical University, Yantai, Shandong, P.R. China.
  • Department of Cardiology, Central Hospital Affiliated to Shandong First Medical University, Jinan, Shandong, P.R. China.

ORCID-Profile: Pengchao Du

Förderung

  • The present study was supported by Shandong Natural Science Fund of Shandong Province
  • Introduction of Talent Research Initiation Fund of Central Hospital Affiliated to Shandong First Medical University
  • The Projects of Medical and Health Technology Development Program in Shandong Province
  • The Projects of Technological Innovation Development Program in Yantai City
  • Traditional Chinese medicine science and technology project of Shandong Province
  • Clinical +X project of Binzhou Medical University

Zitieren

APA

Yang, D., Yin, R., Zhang, X., Wang, X., Pei, X., Guo, Z., Qiao, P., Zhu, K., Wang, L., & Du, P. (2025). Circulating exosome-circRNAs mediated downregulation of FGF9 through ceRNA mechanism aggravates renal fibrosis in diabetic nephropathy. PLOS One. https://doi.org/10.1371/journal.pone.0326217

Vancouver

Yang D, Yin R, Zhang X, Wang X, Pei X, Guo Z, et al. Circulating exosome-circRNAs mediated downregulation of FGF9 through ceRNA mechanism aggravates renal fibrosis in diabetic nephropathy. PLOS One. 2025. doi:10.1371/journal.pone.0326217

BibTeX
@article{Yang2025,
  author = {Yang, Donglin and Yin, Rongjiang and Zhang, Xiaomin and Wang, Xiaohui and Pei, Xiaobin and Guo, Zijie and Qiao, Pengyue and Zhu, Kehan and Wang, Lin and Du, Pengchao},
  title = {Circulating exosome-circRNAs mediated downregulation of FGF9 through ceRNA mechanism aggravates renal fibrosis in diabetic nephropathy},
  journal = {PLOS One},
  year = {2025},
  doi = {10.1371/journal.pone.0326217}
}
Kostenlos starten →